[28V11-pm] トランスポーター①/ADMET, PK/PD①

[28V11-pm20] Role of OATP4C1 in renal handling of remdesivir and its nucleoside analogue GS-441524: the first approved drug for patients with COVID-19

○Toshihiro Sato¹, Masamitsu Maekawa^1,2,3, Takaaki Abe^3,4, Hiroaki Yamaguchi^5,6, Nariyasu Mano^1,2,3 (1. Department of Pharmaceutical Sciences, Tohoku University Hospital, 2. Graduate School of Phamaceutical Sciences, Tohoku University, 3. Graduate School of Medicine, Tohoku University, 4. Graduate School of Biomedical Engineering, Tohoku University, 5. Department of Pharmacy, Yamagata University Hospital, 6. Graduate School of Medical Science, Yamagata University)